Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors
Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.
Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.